P0150 A precision medicine approach for carriers of defined IL2RA polymorphism: JAK inhibition blocks exaggerated IL-2 signalling in vitro, with no difference in in vivo clinical response rates in a small clinical cohort
John D. Clough, Sailish Honap, Andrea Centritto, D Seah et autres